STOCK TITAN
  1. Home
  2. MNKTQ

Mallinckrodt (MNKTQ) Stock Price, News & Analysis

MNKTQ OTC
Published by Stock Titan Data refreshed

What Changed

Price Move History

Daily moves over 5%
100 214 sessions, January 12, 2023 to January 12, 2024
Largest daily move
+457.5% close of May 19, 2023
1-year change
-98.5% closing prices, January 12, 2023 to January 12, 2024
1-month change
+0% closing prices, November 14, 2023 to January 12, 2024

Company Description

MNKTQ has declined 98.5% over the past year. The last closing price was $0.1200.

This page collects what Stock Titan holds for MNKTQ, including price data and latest news.

Stock Performance

Chart
$—
-
-
Last updated:
-98.5%
Performance 1 year
-
Market Cap
-
Shares outstanding

Mallinckrodt (MNKTQ) closed at $0.1200 on January 12, 2024. Over the past 12 months, the price has lost 98.5%.

See what a $1,000 investment in MNKTQ would be worth today

Average down calculator for MNKTQ

Latest News

View All
—

Mallinckrodt Announces Board of Directors and Leadership Updates

management
—

Mallinckrodt Presents New Data on TERLIVAZ® (terlipressin) for Injection at the Society of Critical Care Medicine (SCCM) 2024 Critical Care Congress

-100.00%

Mallinckrodt Completes Financial Restructuring and Irish Examinership Proceedings and Emerges From Chapter 11

+9.00%

Mallinckrodt to Present Breadth of Data on TERLIVAZ® (terlipressin) for Injection in Adult Patients with Hepatorenal Syndrome (HRS) at the American Association for the Study of Liver Diseases (AASLD) 2023 Liver Meeting

conferences
+12.50%

Mallinckrodt plc (in Examinership) Reports Third Quarter 2023 Financial Results

earnings
-8.54%

Mallinckrodt to Present Data on TERLIVAZ® (terlipressin) for Injection in Adult Patients with Hepatorenal Syndrome (HRS) at the American Society of Nephrology (ASN) Kidney Week 2023 Scientific Meeting

conferences
+1.23%

Mallinckrodt Presents Latest Health Economics Data on Acthar® Gel (Repository Corticotropin Injection) at the Academy of Managed Care Pharmacy (AMCP) Nexus 2023

+3.45%

Mallinckrodt to Present Data on TERLIVAZ® (terlipressin) for Injection in Adult Patients with Hepatorenal Syndrome (HRS) at the American College of Gastroenterology (ACG) Annual Scientific Meeting

conferences
-39.39%

Mallinckrodt plc (in examinership) Receives U.S. Court Approval for Financial Restructuring Plan

-39.39%

Mallinckrodt Announces Publication of Two Journal Manuscripts with Clinical and Economic Evidence for Acthar® Gel (Repository Corticotropin Injection)

Mallinckrodt has 10 recent news articles. Of the recent coverage, 4 articles coincided with positive price movement and 4 with negative movement. Key topics include management, conferences, earnings. View all MNKTQ news →

SEC Filings

View All

No SEC filings available for MNKTQ.

Frequently Asked Questions

What is the current quoted price of Mallinckrodt (MNKTQ)?

The current quoted price of Mallinckrodt (MNKTQ) is $0.12 as of January 12, 2024.